The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia

EM Stein, G Garcia-Manero, DA Rizzieri, R Tibes, JG Berdeja, MR Savona, Mojca Jongen - Lavrencic, JK Altman, B Thomson, SJ Blakemore, SR Daigle, NJ Waters, AB Suttle, A Clawson, R Pollock, A Krivtsov, SA Armstrong, J DiMartino, E Hedrick, Bob LöwenbergMS Tallman

Research output: Contribution to journalArticleAcademicpeer-review

289 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2661-2669
Number of pages9
Issue number24
Publication statusPublished - 2018

Research programs

  • EMC MM-02-41-03

Cite this